GlomCon's Clinical Trial Portal
A platform to help HOPE
find OPPORTUNITY
Selected Clinical Trials
Atypical Hemolytic Uremic Syndrome
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy (APPELHUS).
C3 Glomerulopathy
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. (APPEAR-C3G).
IC-MPGN
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN (APPARENT).
IgA Nephropathy
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients (APPLAUSE-IgAN).
Resources
GlomCon's Corporate Supporters
We gratefully acknowledge the support and partnership of corporations dedicated to improving the lives of patients with glomerular diseases.
The support from our corporate members and our strategic partners allows us to come up with bold ideas and helps us pursue our mission.
EnrollMyPatient Team
Dr. Manasi Bapat
Editor in Chief
Dr. Jithu Kurian
Deputy Editor
Dr. Priti Meena
Deputy Editor
Infographics editor
Dr. Anjana Gopal
Deputy Editor
Rica Pitogo
Website Design